Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Siemens Healthineers in advanced talks to buy Varian for $15 billion: Bloomberg News

Published 08/01/2020, 08:16 PM
Updated 08/01/2020, 08:20 PM
© Reuters. Staff work on magnetic resonance imaging machines at a production line of Siemens Healthineers in Shenzhen

© Reuters. Staff work on magnetic resonance imaging machines at a production line of Siemens Healthineers in Shenzhen

(Reuters) - German group Siemens Healthineers AG (DE:SHLG) is in advanced talks to purchase Varian Medical Systems Inc (N:VAR), a maker of devices and software for treating cancer, in a deal that will value the medical device maker at about $15 billion, Bloomberg News reported late on Saturday.

The deal could be announced in the coming days, the report added, citing sources.

The talks could still fall apart, according to Bloomberg.

Both companies did not immediately respond to a request for comment.

Varian, based in Palo Alto, California, is focused on developing and delivering innovative cancer treatments and has 10,000 employees. In 2019, it reported total revenue of $3.2 billion.

Siemens Healthineers, a spinoff from Siemens AG (DE:SIEGn) in 2018, makes X-ray, ultrasound and MRI equipment.

© Reuters. Staff work on magnetic resonance imaging machines at a production line of Siemens Healthineers in Shenzhen

Latest comments

Nothing like good old consolidation in the medical field to drive down prices.... /s
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.